LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 7 of total 7

Search options

  1. Article: Pulmonary Delivery of Favipiravir in Rats Reaches High Local Concentrations without Causing Oxidative Lung Injury or Systemic Side Effects.

    Akbal-Dagistan, Ozlem / Sevim, Mustafa / Sen, Leyla Semiha / Basarir, Nur Sena / Culha, Meltem / Erturk, Aybige / Fael, Hanan / Kaptan, Engin / Sancar, Serap / Mulazimoglu Durmusoglu, Lutfiye / Yegen, Berrak C / Yildiz-Pekoz, Ayca

    Pharmaceutics

    2022  Volume 14, Issue 11

    Abstract: Favipiravir displays a rapid viral clearance, a high recovery rate and broad therapeutic safety; however, its oral administration was associated with systemic side effects in susceptible patients. Considering that the pulmonary route could provide a high ...

    Abstract Favipiravir displays a rapid viral clearance, a high recovery rate and broad therapeutic safety; however, its oral administration was associated with systemic side effects in susceptible patients. Considering that the pulmonary route could provide a high drug concentration, and a safer application with less absorption into systemic circulation, it was aimed to elucidate whether favipiravir delivered via soft-mist inhaler has any deleterious effects on lung, liver and kidney tissues of healthy rats. Wistar albino rats of both sexes (n = 72) were placed in restrainers, and were given either saline or favipiravir (1, 2.5, 5 or 10 mg/kg in 1 mL saline) by inhalation within 2 min for 5 consecutive days. On the 6th day, electrocardiographic recording was obtained, and cardiac blood and lung tissues were collected. Favipiravir did not alter cardiac rhythm, blood cell counts, serum levels of alanine transaminase, aspartate transaminase, blood urea nitrogen, creatinine, urea or uric acid, and did not cause any significant changes in the pulmonary malondialdehyde, myeloperoxidase activity or antioxidant glutathione levels. Our data revealed that pulmonary use of favipiravir via soft-mist inhaler enables a high local concentration compared to plasma without oxidative lung injury or cardiac or hepatorenal dysfunction.
    Language English
    Publishing date 2022-11-04
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2527217-2
    ISSN 1999-4923
    ISSN 1999-4923
    DOI 10.3390/pharmaceutics14112375
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Galectin-9 supports primary T cell transendothelial migration in a glycan and integrin dependent manner.

    Mansour, Adel Abo / Raucci, Federica / Sevim, Mustafa / Saviano, Anella / Begum, Jenefa / Zhi, Zhaogong / Pezhman, Laleh / Tull, Samantha / Maione, Francesco / Iqbal, Asif Jilani

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

    2022  Volume 151, Page(s) 113171

    Abstract: Adaptive immunity relies on the efficient recruitment of T cells from the blood into peripheral tissues. However, the current understanding of factor(s) coordinating these events is incomplete. Previous studies on galectin-9 (Gal-9), have proposed a ... ...

    Abstract Adaptive immunity relies on the efficient recruitment of T cells from the blood into peripheral tissues. However, the current understanding of factor(s) coordinating these events is incomplete. Previous studies on galectin-9 (Gal-9), have proposed a functionally significant role for this lectin in mediating leukocyte adhesion and transmigration. However, very little is known about its function in T cell migration. Here, we have investigated the role of the Gal-9 on the migration behaviour of both human primary CD4
    MeSH term(s) Animals ; CD8-Positive T-Lymphocytes ; Galectins ; Integrins ; Mice ; Polysaccharides ; Transendothelial and Transepithelial Migration
    Chemical Substances Galectins ; Integrins ; Polysaccharides
    Language English
    Publishing date 2022-05-25
    Publishing country France
    Document type Journal Article
    ZDB-ID 392415-4
    ISSN 1950-6007 ; 0753-3322 ; 0300-0893
    ISSN (online) 1950-6007
    ISSN 0753-3322 ; 0300-0893
    DOI 10.1016/j.biopha.2022.113171
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Pulmonary delivery of favipiravir inhalation solution for COVID-19 treatment:

    Yildiz Pekoz, Ayca / Akbal Dagistan, Ozlem / Fael, Hanan / Culha, Meltem / Erturk, Aybige / Basarir, Nur Sena / Sahin, Gokben / Serhatli, Muge / Cakirca, Gamze / Tekin, Saban / Sen, Leyla Semiha / Sevim, Mustafa / Mulazimoglu Durmusoglu, Lutfiye / Yegen, Berrak C

    Drug delivery

    2022  Volume 29, Issue 1, Page(s) 2846–2854

    Abstract: Favipiravir, an RNA-dependent RNA polymerase (RdRp) inhibitor, is used to treat patients infected with influenza virus and most recently with SARS-CoV-2. However, poor accumulation of favipiravir in lung tissue following oral administration has required ... ...

    Abstract Favipiravir, an RNA-dependent RNA polymerase (RdRp) inhibitor, is used to treat patients infected with influenza virus and most recently with SARS-CoV-2. However, poor accumulation of favipiravir in lung tissue following oral administration has required an alternative method of administration that directly targets the lungs. In this study, an inhalation solution of favipiravir at a concentration of 2 mg mL
    MeSH term(s) Amides ; Antiviral Agents/pharmacology ; COVID-19/drug therapy ; Humans ; Lung ; Pyrazines ; Respiratory Aerosols and Droplets ; SARS-CoV-2
    Chemical Substances Amides ; Antiviral Agents ; Pyrazines ; favipiravir (EW5GL2X7E0)
    Language English
    Publishing date 2022-06-23
    Publishing country England
    Document type Journal Article
    ZDB-ID 1213261-5
    ISSN 1521-0464 ; 1071-7544
    ISSN (online) 1521-0464
    ISSN 1071-7544
    DOI 10.1080/10717544.2022.2118398
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Risk factors influencing mortality related to Stenotrophomonas maltophilia infection in hematology-oncology patients.

    Demiraslan, Hayati / Sevim, Mustafa / Pala, Çiğdem / Durmaz, Süleyman / Berk, Veli / Kaynar, Leylagül / Metan, Gökhan

    International journal of hematology

    2013  Volume 97, Issue 3, Page(s) 414–420

    Abstract: Stenotrophomonas maltophilia infection is of concern in patients with cancer. Antibiotics active against S. maltophilia are rarely used in the treatment of febrile neutropenia, making it important to identify the factors influencing mortality in cancer ... ...

    Abstract Stenotrophomonas maltophilia infection is of concern in patients with cancer. Antibiotics active against S. maltophilia are rarely used in the treatment of febrile neutropenia, making it important to identify the factors influencing mortality in cancer patients with S. maltophilia infection. The objective of this study was to analyze the clinical characteristics and outcomes of cancer and hemopathic patients with S. maltophilia infection and assess the factors influencing the mortality. The microbiology laboratory records of Erciyes University, Faculty of Medicine Hospital were reviewed to retrospectively identify patients with S. maltophilia infection between January 2007 and June 2011. A total of 38 patients (25 male, 13 female) were eligible for the study. The median age of the patients was 53 years. The underlying disease was hematological malignancy and disorders in 76.3 % (29 cases), solid tumors in 15.8 % (six cases), aplastic anemia in 7.9 % (three cases), while 18.4 % (seven cases) were hematopoietic stem cell transplantation (HSCT) recipients. An indwelling central venous catheter was used in 32 cases (84.2 %). Twenty-seven patients (71.1 %) were neutropenic at the onset of infection. Nine patients (23.7 %) were receiving corticosteroid therapy. The overall 14-day mortality rate was 50 %. Three of the patients received empirical antibacterial treatment, and three HSCT recipients received trimethoprim-sulfamethoxazole prophylaxis, which is active against S. maltophilia. Severe sepsis (OR 13.24, 95 % confidence interval (CI) 1.62-108.57) and the duration of the treatment (OR 0.73, 95 % CI 0.60-0.90) were related to death based on logistic regression analysis findings. In immunocompromised hematology-oncology patients with severe sepsis, S. maltophilia should be considered as a possible cause of infection, and should be given effective empirical antibiotic treatment immediately; the antimicrobial spectrum may be narrowed according to results of antibiotic susceptibility test.
    MeSH term(s) Adrenal Cortex Hormones/administration & dosage ; Adult ; Aged ; Anti-Infective Agents/administration & dosage ; Female ; Gram-Negative Bacterial Infections/drug therapy ; Gram-Negative Bacterial Infections/etiology ; Gram-Negative Bacterial Infections/microbiology ; Gram-Negative Bacterial Infections/mortality ; Hematopoietic Stem Cell Transplantation ; Humans ; Male ; Middle Aged ; Neoplasms/microbiology ; Neoplasms/mortality ; Neoplasms/therapy ; Neutropenia ; Retrospective Studies ; Sepsis/drug therapy ; Sepsis/etiology ; Sepsis/microbiology ; Sepsis/mortality ; Severity of Illness Index ; Stenotrophomonas maltophilia ; Survival Rate ; Time Factors ; Transplantation, Homologous ; Trimethoprim, Sulfamethoxazole Drug Combination/administration & dosage
    Chemical Substances Adrenal Cortex Hormones ; Anti-Infective Agents ; Trimethoprim, Sulfamethoxazole Drug Combination (8064-90-2)
    Language English
    Publishing date 2013-02-22
    Publishing country Japan
    Document type Clinical Trial ; Journal Article
    ZDB-ID 1076875-0
    ISSN 1865-3774 ; 0917-1258 ; 0925-5710
    ISSN (online) 1865-3774
    ISSN 0917-1258 ; 0925-5710
    DOI 10.1007/s12185-013-1296-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Book: Atatürk kültür, dil ve tarih yüksek kurumu ve ba·glı kurulus̜ları yayınları toplu katalo·gu

    Sevim, Mustafa

    (18 ekim 1983 - 1993)

    1994  

    Institution Türkiye / Devlet Arşivleri Genel Müdürlüğü
    Author's details Mustafa Sevim
    Language Turkish
    Size 100 S
    Publisher Türk tarih kurumu basımevi
    Publishing place Ankara
    Document type Book
    Database Former special subject collection: coastal and deep sea fishing

    More links

    Kategorien

  6. Article ; Online: Retrospective analysis of effectiveness of fingolimod in real life setting in Turkey (REFINE).

    Tuncer, Meryem Aslı / Kürtüncü, Murat / Terzi, Murat / Uygunoğlu, Uğur / Göncüoğlu, Cansu / Yüceyar, Ayşe Nur / Ekmekçi, Özgül / Türkoğlu, Recai / Soysal, Aysun / Köseoğlu, Mesrure / Boz, Cavit / Beckmann, Yeşim / Turan, Ömer Faruk / Demirkıran, Duruhan Meltem / Akman, Firdevs Gülşen / Altunrende, Burcu / Cantürk, İlknur Aydın / Birday, Erkingül / Özcan, Abdulcemal /
    Kamişli, Özden / Özen, Nazire Pinar Acar / Çelik, Rabia Gökçen Gözübatik / Balcı, Fatma Belgin / Efendi, Hüsnü / Sarıkaya, Cansu / Akçalı, Aylin / Toprak, Münire Kılınç / Kabay, Sibel Canbaz / Kızılay, Ferah / Sevim, Mustafa Serhan / Gazaloğlu, Gülcan Baran / Demir, Caner Feyzi / Balgetir, Ferhat / Kıylıoğlu, Nefati / Sarıahmetoğlu, Hande / Ölmez, Çağcan / Mavi, Kamil / Yüksel, Süha / Işık, Nihal / Saip, Sabahattin / Karabudak, Rana / Siva, Aksel / Eraksoy, Mefküre

    Turkish journal of medical sciences

    2023  Volume 53, Issue 1, Page(s) 323–332

    Abstract: Background: During multiple sclerosis (MS) treatment different modes of action such as lateral (interferon beta to glatiramer acetate or glatiramer acetate to interferon beta) or vertical (interferon beta/glatiramer acetate to fingolimod) drug switch ... ...

    Abstract Background: During multiple sclerosis (MS) treatment different modes of action such as lateral (interferon beta to glatiramer acetate or glatiramer acetate to interferon beta) or vertical (interferon beta/glatiramer acetate to fingolimod) drug switch can be performed. This study aims to investigate the clinical effectiveness of switching from the first-line injectable disease modifying treatments (iDMTs) to fingolimod (FNG) compared to switching between first-line iDMTs.
    Methods: This is a multicenter, observational and retrospective study of patients with relapsing-remitting MS who had lateral and vertical switch. The observation period included three key assessment time points (before the switch, at switch, and after the switch). Data were collected from the MS patients' database by neurologists between January 2018 and June 2019. The longest follow-up period of the patients was determined as 24 months after the switch.
    Results: In 462 MS patients that were included in the study, both treatments significantly decreased the number of relapses during the postswitch 12 months versus preswitch one year while patients in the FNG group experienced significantly fewer relapses compared to iDMT cohort in the postswitch 12 months period. FNG cohort experienced fewer relapses than in the iDMT cohort within the postswitch 2 year. The mean time to first relapse after the switch was significantly longer in the FNG group.
    Discussion: The present study revealed superior effectiveness of vertical switch over lateral switch regarding the improvement in relapse outcomes. Patients in the FNG cohort experienced sustainably fewer relapses during the follow-up period after the switch compared the iDMT cohort. Importantly, switching to FNG was more effective in delaying time to first relapse when compared with iDMTs.
    MeSH term(s) Humans ; Fingolimod Hydrochloride/therapeutic use ; Retrospective Studies ; Glatiramer Acetate/therapeutic use ; Immunosuppressive Agents/therapeutic use ; Turkey ; Multiple Sclerosis/drug therapy ; Interferon-beta/therapeutic use ; Recurrence
    Chemical Substances Fingolimod Hydrochloride (G926EC510T) ; Glatiramer Acetate (5M691HL4BO) ; Immunosuppressive Agents ; Interferon-beta (77238-31-4)
    Language English
    Publishing date 2023-02-22
    Publishing country Turkey
    Document type Observational Study ; Multicenter Study ; Journal Article
    ZDB-ID 1183461-4
    ISSN 1303-6165 ; 1300-0144
    ISSN (online) 1303-6165
    ISSN 1300-0144
    DOI 10.55730/1300-0144.5588
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Tailored implementation of internet-based cognitive behavioural therapy in the multinational context of the ImpleMentAll project

    Leah Bührmann / Josien Schuurmans / Jeroen Ruwaard / Margot Fleuren / Anne Etzelmüller / Jordi Piera-Jiménez / Tracy Finch / Tim Rapley / Sebastian Potthoff / Bruno Aouizerate / Philip J. Batterham / Alison Calear / Helen Christensen / Claus Duedal Pedersen / David Daniel Ebert / Erik Van der Eycken / Naim Fanaj / Claire van Genugten / Denise Hanssen /
    Ulrich Hegerl / Juliane Hug / Annet Kleiboer / Kim Mathiasen / Carl May / Sevim Mustafa / Caroline Oehler / Arlinda Cerga-Pashoja / Catherine Pope / Gentiana Qirjako / Judith Rosmalen / Ylenia Sacco / Ludovic Samalin / Mette Maria Skjøth / Kristine Tarp / Ingrid Titzler / Enrico Zanalda / Isabel Zbukvic / Johannes H. Smit / Heleen Riper / Christiaan Vis / on behalf of the ImpleMentAll consortium

    Trials, Vol 21, Iss 1, Pp 1-

    a study protocol for a stepped wedge cluster randomized trial

    2020  Volume 15

    Abstract: Abstract Background Internet-based Cognitive Behavioural Therapy (iCBT) is found effective in treating common mental disorders. However, the use of these interventions in routine care is limited. The international ImpleMentAll study is funded by the ... ...

    Abstract Abstract Background Internet-based Cognitive Behavioural Therapy (iCBT) is found effective in treating common mental disorders. However, the use of these interventions in routine care is limited. The international ImpleMentAll study is funded by the European Union’s Horizon 2020 programme. It is concerned with studying and improving methods for implementing evidence-based iCBT services for common mental disorders in routine mental health care. A digitally accessible implementation toolkit (ItFits-toolkit) will be introduced to mental health care organizations with the aim to facilitate the ongoing implementation of iCBT services within local contexts. This study investigates the effectiveness of the ItFits-toolkit by comparing it to implementation-as-usual activities. Methods A stepped wedge cluster randomized controlled trial (SWT) design will be applied. Over a trial period of 30 months, the ItFits-toolkit will be introduced sequentially in twelve routine mental health care organizations in primary and specialist care across nine countries in Europe and Australia. Repeated measures are applied to assess change over time in the outcome variables. The effectiveness of the ItFits-toolkit will be assessed in terms of the degree of normalization of the use of the iCBT services. Several exploratory outcomes including uptake of the iCBT services will be measured to feed the interpretation of the primary outcome. Data will be collected via a centralized data collection system and analysed using generalized linear mixed modelling. A qualitative process evaluation of routine implementation activities and the use of the ItFits-toolkit will be conducted within this study. Discussion The ImpleMentAll study is a large-scale international research project designed to study the effectiveness of tailored implementation. Using a SWT design that allows to examine change over time, this study will investigate the effect of tailored implementation on the normalization of the use of iCBT services and their uptake. It will provide a better understanding of the process and methods of tailoring implementation strategies. If found effective, the ItFits-toolkit will be made accessible for mental health care service providers, to help them overcome their context-specific implementation challenges. Trial registration ClinicalTrials.gov NCT03652883 . Retrospectively registered on 29 August 2018
    Keywords Tailored implementation ; Normalization ; Implementation strategies ; Determinants of practice ; eHealth ; Mental health ; Medicine (General) ; R5-920
    Subject code 380
    Language English
    Publishing date 2020-10-01T00:00:00Z
    Publisher BMC
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top